Amanote Research
Register
Sign In
Real World Treatment Patterns of Patients With Ovarian Cancer Receiving First Line Chemotherapy in the United States
Value in Health
- United Kingdom
doi 10.1016/j.jval.2017.08.424
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2017
Authors
N Yu
Y Xiao
J Yi
D Oliveri
R Houghton
P Luhn
Publisher
Elsevier BV
Related search
Real-World Treatment Patterns Among Patients Initiating Small Molecule Kinase Inhibitor Therapies for Thyroid Cancer in the United States
Advances in Therapy
Medicine
Pharmacology
Could HE4 Level Measurements During First-Line Chemotherapy Predict Response to Treatment Among Ovarian Cancer Patients?
PLoS ONE
Multidisciplinary
MA15.11 Real World Biomarker Testing and Treatment Patterns in Patients With Advanced NSCLC Receiving EGFR-TKIs
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Primary Chemotherapy Patterns for Ovarian Cancer Treatment in Japan
Journal of Obstetrics and Gynaecology Research
Medicine
Gynecology
Obstetrics
Real-World Cost of Treatment for Multiple Sclerosis Patients Initiating and Receiving Infused Disease-Modifying Therapies Per Recommended Label in the United States
Journal of Medical Economics
Health Policy
Real World Treatment Patterns of PCSK9 Inhibitors Among Patients With Dyslipidemia in Germany, Spain, and United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P3.15-21 Real-World Experience of First-Line Afatinib Treatment in Patients With EGFR Mutant Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Estimated Life-Years Saved in Women With HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Real-World Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib
Clinical Colorectal Cancer
Oncology
Gastroenterology
